Dexamethasone promotes tolerance in vivo by enriching CD11cloCD40lo tolerogenic macrophages

European Journal of Immunology

Volumn 43, Issue 1, 2013, Pages 219-227

  Zheng, Guoxing ^a   Zhong, Shibo ^a   Geng, Yajun ^a   Munirathinam, Gnanasekar ^a   Cha, Isaac ^a   Reardon, Catherine ^b   Getz, Godfrey S ^b   Van Rooijen, Nico ^c   Kang, Youmin ^d   Wang, Bin ^e   Chen, Aoshuang ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d CHINA AGRICULTURAL UNIVERSITY   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

Dexamethasone; Macrophage; Tolerance

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; DEXAMETHASONE; GLYCOPROTEIN P 15095; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; DRUG ACTIVITY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LYMPH NODE; MACROPHAGE; MEMORY T LYMPHOCYTE; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; UPREGULATION;

ANIMALS; ANTIGENS, CD11; ANTIGENS, CD40; ANTIGENS, CD86; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; DEXAMETHASONE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84872434121     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242468     Document Type: Article

References (27)

1. Coffman, R. L., Sher, A. and Seder, R. A., Vaccine adjuvants: putting innate immunity to work. Immunity 2010. 33: 492-503.
2. Chen, X., Oppenheim, J. J., Winkler-Pickett, R. T., Ortaldo, J. R. and Howard, O. M., Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 2006. 36: 2139-2149.
3. Chen, X., Murakami, T., Oppenheim, J. J. and Howard, O. M., Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur. J. Immunol. 2004. 34: 859-869.
4. Hackstein, H. and Thomson, A. W., Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 2004. 4: 24-34.
5. Kang, Y., Xu, L., Wang, B., Chen, A. and Zheng, G., Cutting edge: immunosuppressant as adjuvant for tolerogenic immunization. J. Immunol. 2008. 180: 5172-5176.
6. Fauci, A. S., Dale, D. C. and Balow, J. E., Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann. Intern. Med. 1976. 84: 304-315.
7. Abe, M., Colvin, B. L. and Thomson, A. W., Plasmacytoid dendritic cells: in vivo regulators of alloimmune reactivity? Transplant Proc. 2005. 37: 4119-4121.
8. Ruedl, C., Koebel, P., Bachmann, M., Hess, M. and Karjalainen, K., Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J. Immunol. 2000. 165: 4910-4916.
9. Nakano, H., Lin, K. L., Yanagita, M., Charbonneau, C., Cook, D. N., Kakiuchi, T. and Gunn, M. D., Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat. Immunol. 2009. 10: 394-402.
10. Yona, S. and Jung, S., Monocytes: subsets, origins, fates and functions. Curr. Opin. Hematol. 2010. 17: 53-59.
11. Taylor, P. R., Brown, G. D., Geldhof, A. B., Martinez-Pomares, L. and Gordon, S., Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur. J. Immunol. 2003. 33: 2090-2097.
12. Taylor, P. R., Reid, D. M., Heinsbroek, S. E., Brown, G. D., Gordon, S. and Wong, S. Y., Dectin-2 is predominantly myeloid restricted and exhibits unique activation-dependent expression on maturing inflammatory monocytes elicited in vivo. Eur. J. Immunol. 2005. 35: 2163-2174.
13. Kohyama, M., Ise, W., Edelson, B. T., Wilker, P. R., Hildner, K., Mejia, C., Frazier, W. A. et al., Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 2009. 457: 318-321.
14. Blasius, A. L., Giurisato, E., Cella, M., Schreiber, R. D., Shaw, A. S. and Colonna, M., Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 2006. 177: 3260-3265.
15. Sato, K. and Fujita, S., Dendritic cells: nature and classification. Allergol. Int. 2007. 56: 183-191.
16. Villadangos, J. A. and Heath, W. R., Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm. Semin. Immunol. 2005. 17: 262-272.
17. Rutella, S., Danese, S. and Leone, G., Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006. 108: 1435-1440.
18. van Rooijen, N. and Hendrikx, E., Liposomes for specific depletion of macrophages from organs and tissues. Methods Mol. Biol. 2010. 605: 189-203.
19. Chensue, S. W., Terebuh, P. D., Remick, D. G., Scales, W. E. and Kunkel, S. L., In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am. J. Pathol. 1991. 138: 395-402.
20. Mosser, D. M. and Edwards, J. P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008. 8: 958-969.
21. Zen, M., Canova, M., Campana, C., Bettio, S., Nalotto, L., Rampudda, M., Ramonda, R. et al., The kaleidoscope of glucorticoid effects on immune system. Autoimmun. Rev. 2011. 10: 305-310.
22. Hinds, T. D., Jr., Ramakrishnan, S., Cash, H. A., Stechschulte, L. A., Heinrich, G., Najjar, S. M. and Sanchez, E. R., Discovery of glucocorticoid receptor-beta in mice with a role in metabolism. Mol. Endocrinol. 2010. 24: 1715-1727.
23. Sabat, R., Grutz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K. and Geginat, J., Biology of interleukin-10. Cytokine Growth Factor Rev. 2010. 21: 331-344.
24. Haxhinasto, S., Mathis, D. and Benoist, C., The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 2008. 205: 565-574.
25. Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C. and von Boehmer, H., Inducing and expanding regulatory T-cell populations by foreign antigen. Nat. Immunol. 2005. 6: 1219-1227.
26. Sauer, S., Bruno, L., Hertweck, A., Finlay, D., Leleu, M., Spivakov, M., Knight, Z. A. et al., T-cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 2008. 105: 7797-7802.
27. Turner, M. S., Kane, L. P. and Morel, P. A., Dominant role of antigen dose in CD4+Foxp3+ regulatory T-cell induction and expansion. J. Immunol. 2009. 183: 4895-4903.